Maravai LifeSciences Holdings EBITDA 2019-2025 | MRVI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Maravai LifeSciences Holdings ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Maravai LifeSciences Holdings ebitda from 2019 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$223.7B
Boston Scientific (BSX)	$157.9B
Stryker (SYK)	$152.8B
EssilorLuxottica (ESLOY)	$137.4B
Medtronic (MDT)	$117.5B
Lonza Group Ag (LZAGY)	$49.5B
Haleon (HLN)	$43.3B
ResMed (RMD)	$40.7B
Agilent Technologies (A)	$33.5B
GE HealthCare Technologies (GEHC)	$32.8B
Koninklijke Philips (PHG)	$25.8B
Terumo (TRUMY)	$25.1B
Insulet (PODD)	$21B
Zimmer Biomet Holdings (ZBH)	$18.5B
Baxter (BAX)	$14.4B
Smith & Nephew SNATS (SNN)	$13.5B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.8B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.8B
Prestige Consumer Healthcare (PBH)	$3.7B
Haemonetics (HAE)	$3.6B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
Envista Holdings (NVST)	$3.4B
ICU Medical (ICUI)	$3.1B
LeMaitre Vascular (LMAT)	$1.9B
AtriCure (ATRC)	$1.7B
QuidelOrtho (QDEL)	$1.6B
Acuren (TIC)	$1.4B